Mike is an Assistant Professor in the Department of Biomedical Engineering at Duke University with a secondary appointment in the Chemistry Department.
His team's work is focused on standardizing the engineering of biology using the synthetic biology toolkit. Engineered proteins, enzymes and cells have utility
in numerous applications from fuels and chemicals production to the manufacture of foods, agricultural products, proteins and enzymes and of course in the
development of pharmaceuticals and other therapeutics. Prior to Duke, Mike was at OPX Bio, a company he cofounded out of work from his PhD. He remains in engaged in entrepreneurial activities with two recent new start-ups (DMC Biotechnologies, Inc. and Roke Biotechnologies, LLC.) as well as teaching key aspects of entrepreneurship including: design, product development, technoeconomic analyses, basic business models and intellectual property fundamentals.